Dr. Shaolei Li 李少雷
Chief Physician, Associate Professor
Department of Thoracic Surgery II, Peking University Cancer Hospital, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive surgery and comprehensive care for esophageal cancer, lung cancer, pulmonary nodules, and thymoma. Performs thoracoscopic/laparoscopic esophagectomy with three-field lymph node dissection, various lung resections, and transxiphoid total thymectomy.
Chief Physician and Associate Professor in the Department of Thoracic Surgery at Peking University Cancer Hospital. Serves as a master’s supervisor. Recognized as a Beijing Science and Technology Star and a Chi-Li Pao Scholar at Stanford University.
Professional roles
- Secretary, Esophageal Cancer Professional Committee, Beijing Anti-Cancer Association
- Vice Chair, Thoracic Surgery Professional Committee, Beijing Perioperative Medicine Society
- Member, Thoracic Surgery Branch, China International Exchange and Promotion Association for Medical and Health Care
- Member, Thoracic Surgery Branch, Beijing Medical Association
Name order: in Chinese the family name comes first (Li Shaolei). Papers usually list the name as Shaolei Li or Li S.
Selected publications
76 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Lancet Microbe, 2025 (first author): Evolution's double-edged sword: SARS-CoV-2 adaptation in HIV reveals nature's safety valve. PubMed 40782820
- Clin Lung Cancer, 2023 (first author): An Effective Malignancy Prediction Model for Incidentally Detected Pulmonary Subsolid Nodules Based on Current and Prior CT Scans. PubMed 37596166
- Ann Surg Oncol, 2021 (first author): ASO Author Reflections: Proposed Nodal Categories for Future Editions of the TNM Classification of Non-small Cell Lung Cancer. PubMed 33423120
- Ann Surg Oncol, 2021 (first author): Validation of the 8th Edition Nodal Staging and Proposal of New Nodal Categories for Future Editions of the TNM Classification of Non-Small Cell Lung Cancer. PubMed 33389296
- Transl Cancer Res, 2020 (first author): The prognostic analysis of lung cancer patients with occult malignant pleural disease at thoracotomy. PubMed 35117517
- Transl Cancer Res, 2019 (first author): Five tumor-associated autoantibodies expression levels in serum predict lung cancer and associate with poor outcome. PubMed 35116879
- J Thorac Dis, 2017 (first author): Management of occult malignant pleural disease firstly detected at thoracotomy for non-small cell lung cancer patients. PubMed 29268394
- PLoS One, 2013 (first author): Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of ¹⁸F-FDG PET/CT. PubMed 24205256
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion